Konstantin Konstantinov - Mar 28, 2023 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role
Chief Technology Officer
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Konstantin Konstantinov
Stock symbol
CDAKQ
Transactions as of
Mar 28, 2023
Transactions value $
-$1,874
Form type
4
Date filed
3/30/2023, 05:13 PM
Previous filing
Jan 26, 2023
Next filing
May 22, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDAKQ Common Stock Sale -$1.49K -7.43K -79.37% $0.20* 1.93K Mar 28, 2023 Direct F1
transaction CDAKQ Common Stock Sale -$386 -1.93K -100% $0.20* 0 Mar 28, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 1,932 shares of common stock acquired on June 30, 2022 and December 30, 2022 under the Issuer's Employee Stock Purchase Plan (ESPP).